{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T01:06:35Z","timestamp":1793581595792,"version":"4.5.0"},"reference-count":192,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T00:00:00Z","timestamp":1570665600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"name":"European Society of Human Reproduction and Embryology","award":["2014-01"],"award-info":[{"award-number":["2014-01"]}],"id":[{"id":"https:\/\/ror.org\/028sbah75","id-type":"ROR","asserted-by":"crossref"}]},{"name":"MRC Centre for Reproductive Health","award":["MR\/N022556\/1"],"award-info":[{"award-number":["MR\/N022556\/1"]}],"id":[{"id":"https:\/\/ror.org\/02f4tsf92","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2019,11,5]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Anti-cancer therapy is often a cause of premature ovarian insufficiency and infertility since the ovarian follicle reserve is extremely sensitive to the effects of chemotherapy and radiotherapy. While oocyte, embryo and ovarian cortex cryopreservation can help some women with cancer-induced infertility achieve pregnancy, the development of effective methods to protect ovarian function during chemotherapy would be a significant advantage.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective and rationale<\/jats:title>\n                    <jats:p>This paper critically discusses the different damaging effects of the most common chemotherapeutic compounds on the ovary, in particular, the ovarian follicles and the molecular pathways that lead to that damage. The mechanisms through which fertility-protective agents might prevent chemotherapy drug-induced follicle loss are then reviewed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Search methods<\/jats:title>\n                    <jats:p>Articles published in English were searched on PubMed up to March 2019 using the following terms: ovary, fertility preservation, chemotherapy, follicle death, adjuvant therapy, cyclophosphamide, cisplatin, doxorubicin. Inclusion and exclusion criteria were applied to the analysis of the protective agents.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Outcomes<\/jats:title>\n                    <jats:p>Recent studies reveal how chemotherapeutic drugs can affect the different cellular components of the ovary, causing rapid depletion of the ovarian follicular reserve. The three most commonly used drugs, cyclophosphamide, cisplatin and doxorubicin, cause premature ovarian insufficiency by inducing death and\/or accelerated activation of primordial follicles and increased atresia of growing follicles. They also cause an increase in damage to blood vessels and the stromal compartment and increment inflammation. In the past 20 years, many compounds have been investigated as potential protective agents to counteract these adverse effects. The interactions of recently described fertility-protective agents with these damage pathways are discussed.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Wider implications<\/jats:title>\n                    <jats:p>Understanding the mechanisms underlying the action of chemotherapy compounds on the various components of the ovary is essential for the development of efficient and targeted pharmacological therapies that could protect and prolong female fertility. While there are increasing preclinical investigations of potential fertility preserving adjuvants, there remains a lack of approaches that are being developed and tested clinically.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1093\/humupd\/dmz027","type":"journal-article","created":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T15:11:44Z","timestamp":1564672304000},"page":"673-693","source":"Crossref","is-referenced-by-count":596,"title":["Ovarian damage from chemotherapy and current approaches to its protection"],"prefix":"10.1093","volume":"25","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5604-1974","authenticated-orcid":false,"given":"N","family":"Spears","sequence":"first","affiliation":[{"name":"Biomedical Sciences, University of Edinburgh, Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Lopes","sequence":"additional","affiliation":[{"name":"Biomedical Sciences, University of Edinburgh, Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Stefansdottir","sequence":"additional","affiliation":[{"name":"Biomedical Sciences, University of Edinburgh, Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rossi","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"De Felici","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R A","family":"Anderson","sequence":"additional","affiliation":[{"name":"MRC Centre for Reproductive Health, University of Edinburgh, Edinburgh UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6744-0850","authenticated-orcid":false,"given":"F G","family":"Klinger","sequence":"additional","affiliation":[{"name":"Department of Biomedicine and Prevention, University of Rome Tor Vergata, Rome, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2019,10,10]]},"reference":[{"key":"2019111117231231000_ref1","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053810","article-title":"Pharmacological inhibition of mTORC1 prevents over-activation of the primordial follicle pool in response to elevated PI3K signaling","volume":"8","author":"Adhikari","year":"2013","journal-title":"PLoS One"},{"key":"2019111117231231000_ref2","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/hmg\/ddp483","article-title":"Tsc\/mTORC1 signaling in oocytes governs the quiescence and activation of primordial follicles","volume":"19","author":"Adhikari","year":"2010","journal-title":"Hum Mol Genet"},{"key":"2019111117231231000_ref3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058491","article-title":"Nano-encapsulation of arsenic trioxide enhances efficacy against murine lymphoma model while minimizing its impact on ovarian reserve in vitro and in vivo","volume":"8","author":"Ahn","year":"2013","journal-title":"PLoS One"},{"key":"2019111117231231000_ref4","doi-asserted-by":"crossref","first-page":"328","DOI":"10.3802\/jgo.2014.25.4.328","article-title":"Granulocyte-colony stimulating factor decreases the extent of ovarian damage caused by cisplatin in an experimental rat model","volume":"25","author":"Akdemir","year":"2014","journal-title":"J Gynecol Oncol"},{"key":"2019111117231231000_ref5","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1002\/jcp.20318","article-title":"Stem cells and pulmonary metamorphosis: new concepts in repair and regeneration","volume":"204","author":"Aliotta","year":"2005","journal-title":"J Cell Physiol"},{"key":"2019111117231231000_ref6","doi-asserted-by":"crossref","first-page":"327240","DOI":"10.1155\/2013\/327240","article-title":"The effect of mirtazapine on cisplatin-induced oxidative damage and infertility in rat ovaries","volume":"2013","author":"Altuner","year":"2013","journal-title":"ScientificWorldJournal"},{"key":"2019111117231231000_ref7","doi-asserted-by":"crossref","first-page":"4912","DOI":"10.1158\/0008-5472.CAN-04-0673","article-title":"Augmenting chemosensitivity of malignant melanoma tumors via proteasome inhibition: implication for bortezomib (VELCADE, PS-341) as a therapeutic agent for malignant melanoma","volume":"64","author":"Amiri","year":"2004","journal-title":"Cancer Res"},{"key":"2019111117231231000_ref8","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1093\/humrep\/dey216","article-title":"The impact of cancer on subsequent chance of pregnancy: a population-based analysis","volume":"33","author":"Anderson","year":"2018","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref9","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/S2213-8587(15)00039-X","article-title":"Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults","volume":"3","author":"Anderson","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2019111117231231000_ref10","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/humupd\/dmw007","article-title":"Oocyte cryopreservation: where are we now?","volume":"22","author":"Argyle","year":"2016","journal-title":"Hum Reprod Update"},{"key":"2019111117231231000_ref11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133985","article-title":"Effect of previous chemotherapy on the quality of cryopreserved human ovarian tissue in vitro","volume":"10","author":"Asadi Azarbaijani","year":"2015","journal-title":"PLoS One"},{"key":"2019111117231231000_ref12","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-079X.2006.00327.x","article-title":"Chemoprotective effect of melatonin against cisplatin-induced testicular toxicity in rats","volume":"41","author":"Atessahin","year":"2006","journal-title":"J Pineal Res"},{"key":"2019111117231231000_ref13","doi-asserted-by":"crossref","first-page":"3156","DOI":"10.1242\/dev.147256","article-title":"Hes 5 regulates the transition timing of neurogenesis and gliogenesis in mammalian neocortical development","volume":"144","author":"Bansod","year":"2017","journal-title":"Development"},{"key":"2019111117231231000_ref14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1067\/S0002-9378(03)00837-8","article-title":"Pregnancy outcome in women treated with doxorubicin for childhood cancer","volume":"189","author":"Bar","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"2019111117231231000_ref15","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1093\/biolre\/iox053","article-title":"Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity","volume":"96","author":"Barberino","year":"2017","journal-title":"Biol Reprod"},{"key":"2019111117231231000_ref16","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.reprotox.2008.09.014","article-title":"Previous maternal chemotherapy by cyclophosphamide (cp) causes numerical chromosome abnormalities in preimplantation mouse embryos","volume":"26","author":"Barekati","year":"2008","journal-title":"Reprod Toxicol"},{"key":"2019111117231231000_ref17","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.reprotox.2010.07.003","article-title":"Doxorubicin-induced apoptosis in germinal vesicle (GV) oocytes","volume":"30","author":"Bar-Joseph","year":"2010","journal-title":"Reprod Toxicol"},{"key":"2019111117231231000_ref18","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2217\/fon-2016-0176","article-title":"Chemotherapy-induced damage to ovary: mechanisms and clinical impact","volume":"12","author":"Bedoschi","year":"2016","journal-title":"Future Oncol"},{"key":"2019111117231231000_ref19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.23736\/S0031-0808.18.03494-8","article-title":"Novel insights into the pathophysiology of chemotherapy-induced damage to the ovary","volume":"61","author":"Bedoschi","year":"2019","journal-title":"Panminerva Med"},{"key":"2019111117231231000_ref20","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/1477-7827-8-20","article-title":"Doxorubicin-induced ovarian toxicity","volume":"8","author":"Ben-Aharon","year":"2010","journal-title":"Reprod Biol Endocrinol"},{"key":"2019111117231231000_ref21","first-page":"2912","article-title":"GnRH agonist leuprolide acetate does not confer any protection against ovarian damage induced by chemotherapy and radiation in vitro","volume":"30","author":"Bildik","year":"2015","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref22","doi-asserted-by":"crossref","first-page":"249","DOI":"10.7326\/0003-4819-80-2-249","article-title":"Adriamycin. A new anticancer drug with significant clinical activity","volume":"80","author":"Blum","year":"1974","journal-title":"Ann Intern Med"},{"key":"2019111117231231000_ref23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1126\/science.1247671","article-title":"Reversal of female infertility by Chk2 ablation reveals the oocyte DNA damage checkpoint pathway","volume":"343","author":"Bolcun-Filas","year":"2014","journal-title":"Science"},{"key":"2019111117231231000_ref24","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1158\/0008-5472.CAN-06-2802","article-title":"Sphingosine-1-phosphate protects proliferating endothelial cells from ceramide-induced apoptosis but not from DNA damage-induced mitotic death","volume":"67","author":"Bonnaud","year":"2007","journal-title":"Cancer Res"},{"key":"2019111117231231000_ref25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.reprotox.2017.02.002","article-title":"Multidrug resistance transporter-1 and breast cancer resistance protein protect against ovarian toxicity, and are essential in ovarian physiology","volume":"69","author":"Brayboy","year":"2017","journal-title":"Reprod Toxicol"},{"key":"2019111117231231000_ref26","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1016\/j.fertnstert.2013.07.002","article-title":"Multidrug-resistant transport activity protects oocytes from chemotherapeutic agents and changes during oocyte maturation","volume":"100","author":"Brayboy","year":"2013","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref27","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1200\/JCO.1999.17.9.2670","article-title":"Outcome and reproductive function after chemotherapy for ovarian dysgerminoma","volume":"17","author":"Brewer","year":"1999","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref28","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1210\/en.2012-1158","article-title":"The role of anti-Mullerian hormone (AMH) during follicle development in a monovulatory species (sheep)","volume":"153","author":"Campbell","year":"2012","journal-title":"Endocrinology"},{"key":"2019111117231231000_ref29","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1093\/humrep\/del165","article-title":"Anti-Mullerian hormone inhibits initiation of growth of human primordial ovarian follicles in vitro","volume":"21","author":"Carlsson","year":"2006","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref30","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-079X.2009.00727.x","article-title":"Synergistic antitumor effect of melatonin with several chemotherapeutic drugs on human Ewing sarcoma cancer cells: potentiation of the extrinsic apoptotic pathway","volume":"48","author":"Casado-Zapico","year":"2010","journal-title":"J Pineal Res"},{"key":"2019111117231231000_ref31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144245","article-title":"Cisplatin induces overactivation of the dormant primordial follicle through PTEN\/AKT\/FOXO3a pathway which leads to loss of ovarian reserve in mice","volume":"10","author":"Chang","year":"2015","journal-title":"PLoS One"},{"key":"2019111117231231000_ref32","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1210\/jc.2016-3723","article-title":"Premature ovarian insufficiency in childhood cancer survivors: a report from the St. Jude Lifetime Cohort","volume":"102","author":"Chemaitilly","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"2019111117231231000_ref33","article-title":"Follicle loss and apoptosis in cyclophosphamide-treated mice: what\u2019s the matter?","volume":"17","author":"Chen","year":"2016","journal-title":"Int J Mol Sci"},{"key":"2019111117231231000_ref34","doi-asserted-by":"crossref","first-page":"6387","DOI":"10.1074\/jbc.M114.605261","article-title":"Rictor\/mTORC2 pathway in oocytes regulates folliculogenesis, and its inactivation causes premature ovarian failure","volume":"290","author":"Chen","year":"2015","journal-title":"J Biol Chem"},{"key":"2019111117231231000_ref35","doi-asserted-by":"crossref","first-page":"2670","DOI":"10.1093\/annonc\/mdx360","article-title":"Long-term toxicity of cisplatin in germ-cell tumor survivors","volume":"28","author":"Chovanec","year":"2017","journal-title":"Ann Oncol"},{"key":"2019111117231231000_ref36","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/S1470-2045(16)00086-3","article-title":"Pregnancy after chemotherapy in male and female survivors of childhood cancer treated between 1970 and 1999: a report from the childhood cancer survivor study cohort","volume":"17","author":"Chow","year":"2016","journal-title":"Lancet Oncol"},{"key":"2019111117231231000_ref37","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-019-0499-z","article-title":"The European Society for Blood and Marrow Transplantation (EBMT) consensus recommendations for donor selection in haploidentical hematopoietic cell transplantation","author":"Ciurea","year":"2019","journal-title":"Bone Marrow Transplant"},{"key":"2019111117231231000_ref38","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.semcdb.2015.07.003","article-title":"Epigenetic inheritance through the female germ-line: the known, the unknown, and the possible","volume":"43","author":"Clarke","year":"2015","journal-title":"Semin Cell Dev Biol"},{"key":"2019111117231231000_ref39","first-page":"2445","article-title":"Doxorubicin-derived metabolites induce release of cytochrome C and inhibition of respiration on cardiac isolated mitochondria","volume":"23","author":"Clementi","year":"2003","journal-title":"Anticancer Res"},{"key":"2019111117231231000_ref40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0093311","article-title":"Fetal cyclophosphamide exposure induces testicular cancer and reduced spermatogenesis and ovarian follicle numbers in mice","volume":"9","author":"Comish","year":"2014","journal-title":"PLoS One"},{"key":"2019111117231231000_ref41","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1002\/cncr.31551","article-title":"Annual report to the nation on the status of cancer, part I: national cancer statistics","volume":"124","author":"Cronin","year":"2018","journal-title":"Cancer"},{"key":"2019111117231231000_ref42","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1038\/381800a0","article-title":"Suppression of ceramide-mediated programmed cell death by sphingosine-1-phosphate","volume":"381","author":"Cuvillier","year":"1996","journal-title":"Nature"},{"key":"2019111117231231000_ref43","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1073\/pnas.0810012106","article-title":"Inferring biological mechanisms from spatial analysis: prediction of a local inhibitor in the ovary","volume":"106","author":"Da Silva-Buttkus","year":"2009","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111117231231000_ref44","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/sj.neo.7900122","article-title":"Cisplatinum and taxol induce different patterns of p53 phosphorylation","volume":"3","author":"Damia","year":"2001","journal-title":"Neoplasia"},{"key":"2019111117231231000_ref45","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.ejphar.2014.07.025","article-title":"Cisplatin in cancer therapy: molecular mechanisms of action","volume":"740","author":"Dasari","year":"2014","journal-title":"Eur J Pharmacol"},{"key":"2019111117231231000_ref46","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.ctrv.2013.12.001","article-title":"Gonadotropin-releasing hormone analogues for the prevention of chemotherapy-induced premature ovarian failure in cancer women: systematic review and meta-analysis of randomized trials","volume":"40","author":"Del Mastro","year":"2014","journal-title":"Cancer Treat Rev"},{"key":"2019111117231231000_ref47","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/humrep\/dep008","article-title":"Superficial ovarian cortex vascularization is inversely related to the follicle reserve in normal cycling ovaries and is increased in polycystic ovary syndrome","volume":"24","author":"Delgado-Rosas","year":"2009","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref48","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1200\/JCO.2015.65.8864","article-title":"No evidence for the benefit of gonadotropin-releasing hormone agonist in preserving ovarian function and fertility in lymphoma survivors treated with chemotherapy: final Long-term report of a prospective randomized trial","volume":"34","author":"Demeestere","year":"2016","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref49","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2019.1631111","article-title":"Pre-conceptional maternal exposure to cyclophosphamide results in modifications of DNA methylation in F1 and F2 mouse oocytes: evidence for transgenerational effects","author":"Di Emidio","year":"2019","journal-title":"Epigenetics"},{"key":"2019111117231231000_ref50","doi-asserted-by":"crossref","first-page":"8928604","DOI":"10.1155\/2017\/8928604","article-title":"The natural carotenoid crocetin and the synthetic tellurium compound AS101 protect the ovary against cyclophosphamide by modulating SIRT1 and mitochondrial markers","volume":"2017","author":"Di Emidio","year":"2017","journal-title":"Oxid Med Cell Longev"},{"key":"2019111117231231000_ref51","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1056\/NEJMra1614676","article-title":"Fertility preservation in women","volume":"377","author":"Donnez","year":"2017","journal-title":"N Engl J Med"},{"key":"2019111117231231000_ref52","doi-asserted-by":"crossref","first-page":"5789","DOI":"10.1210\/endo.140.12.7204","article-title":"Control of primordial follicle recruitment by anti-Mullerian hormone in the mouse ovary","volume":"140","author":"Durlinger","year":"1999","journal-title":"Endocrinology"},{"key":"2019111117231231000_ref53","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1093\/humrep\/dex238","article-title":"Dormancy and activation of human oocytes from primordial and primary follicles: molecular clues to oocyte regulation","volume":"32","author":"Ernst","year":"2017","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref54","volume-title":"Management of women with premature ovarian insufficiency","author":"European Society of Human Reproduction and Embryology","year":"2015"},{"key":"2019111117231231000_ref55","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1093\/molehr\/gau065","article-title":"Ovarian stimulation using human chorionic gonadotrophin impairs blastocyst implantation and decidualization by altering ovarian hormone levels and downstream signaling in mice","volume":"20","author":"Ezoe","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"2019111117231231000_ref56","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1073\/pnas.84.1.265","article-title":"Expression of a multidrug-resistance gene in human tumors and tissues","volume":"84","author":"Fojo","year":"1987","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111117231231000_ref57","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/art.1780160204","article-title":"Cyclophosphamide therapy in systemic lupus erythematosus and polymyositis","volume":"16","author":"Fries","year":"1973","journal-title":"Arthritis Rheum"},{"key":"2019111117231231000_ref58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1095\/biolreprod.115.129759","article-title":"Ghrelin prevents cisplatin-induced testicular damage by facilitating repair of DNA double strand breaks through activation of p53 in mice","volume":"93","author":"Garcia","year":"2015","journal-title":"Biol Reprod"},{"key":"2019111117231231000_ref59","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0144099","article-title":"Crowding and follicular fate: spatial determinants of follicular reserve and activation of follicular growth in the mammalian ovary","volume":"10","author":"Gaytan","year":"2015","journal-title":"PLoS One"},{"key":"2019111117231231000_ref60","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1073\/pnas.1617233114","article-title":"mTORC1\/2 inhibition preserves ovarian function and fertility during genotoxic chemotherapy","volume":"114","author":"Goldman","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"2019111117231231000_ref61","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1038\/nm.2033","article-title":"Inhibition of the c-Abl-TAp63 pathway protects mouse oocytes from chemotherapy-induced death","volume":"15","author":"Gonfloni","year":"2009","journal-title":"Nat Med"},{"key":"2019111117231231000_ref62","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the childhood cancer survivor study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref63","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1093\/humrep\/dey250","article-title":"Dynamics of PI3K and hippo signaling pathways during in vitro human follicle activation","volume":"33","author":"Grosbois","year":"2018","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref64","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1002\/cncr.22081","article-title":"Treatment of pregnant breast cancer patients and outcomes of children exposed to chemotherapy in utero","volume":"107","author":"Hahn","year":"2006","journal-title":"Cancer"},{"key":"2019111117231231000_ref65","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0052576","article-title":"HDAC inhibitor L-carnitine and proteasome inhibitor bortezomib synergistically exert anti-tumor activity in vitro and in vivo","volume":"7","author":"Huang","year":"2012","journal-title":"PLoS One"},{"key":"2019111117231231000_ref66","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/jpi.12316","article-title":"Melatonin prevents cisplatin-induced primordial follicle loss via suppression of PTEN\/AKT\/FOXO3a pathway activation in the mouse ovary","volume":"60","author":"Jang","year":"2016","journal-title":"J Pineal Res"},{"key":"2019111117231231000_ref67","doi-asserted-by":"crossref","DOI":"10.1111\/jpi.12432","article-title":"Synergistic effect of melatonin and ghrelin in preventing cisplatin-induced ovarian damage via regulation of FOXO3a phosphorylation and binding to the p27(Kip1) promoter in primordial follicles","volume":"63","author":"Jang","year":"2017","journal-title":"J Pineal Res"},{"key":"2019111117231231000_ref68","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/0890-6238(91)90019-C","article-title":"The short-term reproductive toxicity of cyclophosphamide in the female rat","volume":"5","author":"Jarrell","year":"1991","journal-title":"Reprod Toxicol"},{"key":"2019111117231231000_ref69","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/17446651.2018.1455498","article-title":"Ovarian function, fertility and reproductive lifespan in cancer patients","volume":"13","author":"Jayasinghe","year":"2018","journal-title":"Expert Rev Endocrinol Metab"},{"key":"2019111117231231000_ref70","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.ydbio.2008.06.017","article-title":"Foxo3 is a PI3K-dependent molecular switch controlling the initiation of oocyte growth","volume":"321","author":"John","year":"2008","journal-title":"Dev Biol"},{"key":"2019111117231231000_ref71","first-page":"1499","article-title":"Protective and restorative role of AS101 in combination with chemotherapy","volume":"51","author":"Kalechman","year":"1991","journal-title":"Cancer Res"},{"key":"2019111117231231000_ref72","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3005402","article-title":"Cyclophosphamide triggers follicle activation and \u2018burnout\u2019; AS101 prevents follicle loss and preserves fertility","volume":"5","author":"Kalich-Philosoph","year":"2013","journal-title":"Sci Transl Med"},{"key":"2019111117231231000_ref73","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1053\/beog.2002.0307","article-title":"Chemotherapy for advanced epithelial ovarian carcinoma","volume":"16","author":"Kalil","year":"2002","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"2019111117231231000_ref74","doi-asserted-by":"crossref","first-page":"E1688","DOI":"10.1073\/pnas.1620729114","article-title":"AMH\/MIS as a contraceptive that protects the ovarian reserve during chemotherapy","volume":"114","author":"Kano","year":"2017","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111117231231000_ref75","doi-asserted-by":"crossref","first-page":"17474","DOI":"10.1073\/pnas.1312830110","article-title":"Hippo signaling disruption and Akt stimulation of ovarian follicles for infertility treatment","volume":"110","author":"Kawamura","year":"2013","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2019111117231231000_ref76","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/s41418-018-0107-6","article-title":"CHK2 sets the stage for CK1 in oocyte quality control","volume":"25","author":"Kehrloesser","year":"2018","journal-title":"Cell Death Differ"},{"key":"2019111117231231000_ref77","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrc2167","article-title":"The resurgence of platinum-based cancer chemotherapy","volume":"7","author":"Kelland","year":"2007","journal-title":"Nat Rev Cancer"},{"key":"2019111117231231000_ref78","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.molcel.2012.08.017","article-title":"DNA damage-induced primordial follicle oocyte apoptosis and loss of fertility require TAp63-mediated induction of Puma and Noxa","volume":"48","author":"Kerr","year":"2012","journal-title":"Mol Cell"},{"key":"2019111117231231000_ref79","doi-asserted-by":"crossref","first-page":"1682","DOI":"10.1177\/1535370215576304","article-title":"Protective effect of mirtazapine and hesperidin on cyclophosphamide-induced oxidative damage and infertility in rat ovaries","volume":"240","author":"Khedr","year":"2015","journal-title":"Exp Biol Med (Maywood)"},{"key":"2019111117231231000_ref80","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1038\/cdd.2013.31","article-title":"Rescue of platinum-damaged oocytes from programmed cell death through inactivation of the p53 family signaling network","volume":"20","author":"Kim","year":"2013","journal-title":"Cell Death Differ"},{"key":"2019111117231231000_ref81","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/s41418-018-0151-2","article-title":"Transient inhibition of p53 homologs protects ovarian function from two distinct apoptotic pathways triggered by anticancer therapies","volume":"26","author":"Kim","year":"2018","journal-title":"Cell Death Differ"},{"key":"2019111117231231000_ref82","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.mrrev.2018.11.002","article-title":"Risks of aneuploidy induction from chemical exposure: twenty years of collaborative research in Europe from basic science to regulatory implications","volume":"779","author":"Kirsch-Volders","year":"2019","journal-title":"Mutat Res"},{"key":"2019111117231231000_ref83","doi-asserted-by":"crossref","first-page":"1853","DOI":"10.1016\/S0024-3205(98)00151-9","article-title":"Proteasome is a carrier to translocate doxorubicin from cytoplasm into nucleus","volume":"62","author":"Kiyomiya","year":"1998","journal-title":"Life Sci"},{"key":"2019111117231231000_ref84","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1634\/theoncologist.11-2-96","article-title":"The influence of endocrine effects of adjuvant therapy on quality of life outcomes in younger breast cancer survivors","volume":"11","author":"Knobf","year":"2006","journal-title":"Oncologist"},{"key":"2019111117231231000_ref85","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clon.2013.11.022","article-title":"Bortezomib in multiple myeloma: a practice guideline","volume":"26","author":"Kouroukis","year":"2014","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"2019111117231231000_ref86","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/1097-0142(197704)39:4<1403::AID-CNCR2820390408>3.0.CO;2-8","article-title":"Cyclophosphamide-induced ovarian failure and its therapeutic significance in patients with breast cancer","volume":"39","author":"Koyama","year":"1977","journal-title":"Cancer"},{"key":"2019111117231231000_ref87","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142588","article-title":"Dexrazoxane diminishes doxorubicin-induced acute ovarian damage and preserves ovarian function and fecundity in mice","volume":"10","author":"Kropp","year":"2015","journal-title":"PLoS One"},{"key":"2019111117231231000_ref88","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/4fffb4ef-31ad-4aab-bfce-2c97522c9af4","article-title":"Chemotherapy-induced late transgenerational effects in mice","volume":"6","author":"Kujjo","year":"2011","journal-title":"PLoS One"},{"key":"2019111117231231000_ref89","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1200\/JCO.2018.78.0858","article-title":"Gonadotropin-releasing hormone agonists during chemotherapy for preservation of ovarian function and fertility in premenopausal patients with early breast cancer: a systematic review and meta-analysis of individual patient-level data","volume":"36","author":"Lambertini","year":"2018","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref90","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.rbmo.2016.10.005","article-title":"Short-term exposure of human ovarian follicles to cyclophosphamide metabolites seems to promote follicular activation in vitro","volume":"34","author":"Lande","year":"2017","journal-title":"Reprod Biomed Online"},{"key":"2019111117231231000_ref91","doi-asserted-by":"crossref","first-page":"357","DOI":"10.2147\/CMAR.S47238","article-title":"Dexrazoxane for the treatment of chemotherapy-related side effects","volume":"6","author":"Langer","year":"2014","journal-title":"Cancer Manag Res"},{"key":"2019111117231231000_ref92","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1093\/annonc\/mdx184","article-title":"GnRH agonist for protection against ovarian toxicity during chemotherapy for early breast cancer: the Anglo Celtic group OPTION trial","volume":"28","author":"Leonard","year":"2017","journal-title":"Ann Oncol"},{"key":"2019111117231231000_ref93","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1517\/14622416.6.2.115","article-title":"Mechanisms of resistance to anticancer drugs: the role of the polymorphic ABC transporters ABCB1 and ABCG2","volume":"6","author":"Lepper","year":"2005","journal-title":"Pharmacogenomics"},{"key":"2019111117231231000_ref94","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.26403","article-title":"Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer"},{"key":"2019111117231231000_ref95","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1093\/humrep\/det391","article-title":"Sphingosine-1-phosphate prevents chemotherapy-induced human primordial follicle death","volume":"29","author":"Li","year":"2014","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref96","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1080\/09513590.2017.1290072","article-title":"Sphingosine-1-phosphate activates the AKT pathway to inhibit chemotherapy induced human granulosa cell apoptosis","volume":"33","author":"Li","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"2019111117231231000_ref97","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3802\/jgo.2013.24.2.177","article-title":"The mechanism of mesna in protection from cisplatin-induced ovarian damage in female rats","volume":"24","author":"Li","year":"2013","journal-title":"J Gynecol Oncol"},{"key":"2019111117231231000_ref98","doi-asserted-by":"crossref","first-page":"799","DOI":"10.14694\/EDBK_174708","article-title":"Fertility, cardiac, and orthopedic challenges in survivors of adult and childhood sarcoma","volume":"37","author":"Lipshultz","year":"2017","journal-title":"Am Soc Clin Oncol Educ Book"},{"key":"2019111117231231000_ref99","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1038\/nrendo.2016.164","article-title":"Hormone-replacement therapy: current thinking","volume":"13","author":"Lobo","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"2019111117231231000_ref100","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/JOE-18-0370","article-title":"Inhibitors of apoptosis protect the ovarian reserve from cyclophosphamide","volume":"240","author":"Luan","year":"2019","journal-title":"J Endocrinol"},{"key":"2019111117231231000_ref101","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.lfs.2017.05.001","article-title":"Role of SDF-1\/CXCR4 and cytokines in the development of ovary injury in chemotherapy drug induced premature ovarian failure mice","volume":"179","author":"Luo","year":"2017","journal-title":"Life Sci"},{"key":"2019111117231231000_ref102","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/toxsci\/kfu146","article-title":"Ovarian xenobiotic biotransformation enzymes are altered during phosphoramide mustard-induced ovotoxicity","volume":"141","author":"Madden","year":"2014","journal-title":"Toxicol Sci"},{"key":"2019111117231231000_ref103","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1038\/nm.2852","article-title":"Reply to: Cisplatin-induced primordial follicle oocyte killing and loss of fertility are not prevented by imatinib","volume":"18","author":"Maiani","year":"2012","journal-title":"Nat Med"},{"key":"2019111117231231000_ref104","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1196\/annals.1299.120","article-title":"Tellurium compound AS101 induces PC12 differentiation and rescues the neurons from apoptotic death","volume":"1010","author":"Makarovsky","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"2019111117231231000_ref105","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1006\/gyno.1994.1221","article-title":"Menstrual and hormone patterns in women treated with high-dose cisplatin and bleomycin","volume":"54","author":"Maneschi","year":"1994","journal-title":"Gynecol Oncol"},{"key":"2019111117231231000_ref106","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1093\/humrep\/dem027","article-title":"Cortical fibrosis and blood-vessels damage in human ovaries exposed to chemotherapy. Potential mechanisms of ovarian injury","volume":"22","author":"Meirow","year":"2007","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref107","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1093\/humrep\/16.4.632","article-title":"Administration of cyclophosphamide at different stages of follicular maturation in mice: effects on reproductive performance and fetal malformations","volume":"16","author":"Meirow","year":"2001","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref108","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1093\/humrep\/14.7.1903","article-title":"Subclinical depletion of primordial follicular reserve in mice treated with cyclophosphamide: clinical importance and proposed accurate investigative tool","volume":"14","author":"Meirow","year":"1999","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref109","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1093\/humupd\/7.6.535","article-title":"The effects of radiotherapy and chemotherapy on female reproduction","volume":"7","author":"Meirow","year":"2001","journal-title":"Hum Reprod Update"},{"key":"2019111117231231000_ref110","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s13048-018-0409-9","article-title":"Beneficial effects of curcumin and capsaicin on cyclophosphamide-induced premature ovarian failure in a rat model","volume":"11","author":"Melekoglu","year":"2018","journal-title":"J Ovarian Res"},{"key":"2019111117231231000_ref111","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.fertnstert.2014.05.040","article-title":"Sphingosine-1-phosphate suppresses cyclophosphamide induced follicle apoptosis in human fetal ovarian xenografts in nude mice","volume":"102","author":"Meng","year":"2014","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref112","doi-asserted-by":"crossref","first-page":"190","DOI":"10.3181\/00379727-133-34438","article-title":"Changes in mouse ovaries after prolonged treatment with cyclophosphamide","volume":"133","author":"Miller","year":"1970","journal-title":"Proc Soc Exp Biol Med"},{"key":"2019111117231231000_ref113","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/0002-9343(71)90341-X","article-title":"Multiple late complications of therapy with cyclophosphamide, including ovarian destruction","volume":"50","author":"Miller","year":"1971","journal-title":"Am J Med"},{"key":"2019111117231231000_ref115","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"2019111117231231000_ref116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0173355","article-title":"Maternal cancer and congenital anomalies in children - a Danish nationwide cohort study","volume":"12","author":"Momen","year":"2017","journal-title":"PLoS One"},{"key":"2019111117231231000_ref117","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1371\/journal.pone.0070117","article-title":"Cisplatin and doxorubicin induce distinct mechanisms of ovarian follicle loss; imatinib provides selective protection only against cisplatin","volume":"8","author":"Morgan","year":"2013","journal-title":"PLoS One"},{"key":"2019111117231231000_ref118","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/80442","article-title":"Oocyte apoptosis is suppressed by disruption of the acid sphingomyelinase gene or by sphingosine-1-phosphate therapy","volume":"6","author":"Morita","year":"2000","journal-title":"Nat Med"},{"key":"2019111117231231000_ref119","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1530\/REP-13-0666","article-title":"PUMA regulates germ cell loss and primordial follicle endowment in mice","volume":"148","author":"Myers","year":"2014","journal-title":"Reproduction"},{"key":"2019111117231231000_ref120","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1038\/s41419-018-0633-7","article-title":"Loss of PUMA protects the ovarian reserve during DNA-damaging chemotherapy and preserves fertility","volume":"9","author":"Nguyen","year":"2018","journal-title":"Cell Death Dis"},{"key":"2019111117231231000_ref121","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/cncr.23071","article-title":"Quantitative assessment of the impact of chemotherapy on ovarian follicle reserve and stromal function","volume":"110","author":"Oktem","year":"2007","journal-title":"Cancer"},{"key":"2019111117231231000_ref122","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.ctrv.2016.11.006","article-title":"Chemotherapy-related late adverse effects on ovarian function in female survivors of childhood and young adult cancer: a systematic review","volume":"53","author":"Overbeek","year":"2017","journal-title":"Cancer Treat Rev"},{"key":"2019111117231231000_ref123","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.rbmo.2015.06.007","article-title":"Protective effect of resveratrol against oxidative damage to ovarian reserve in female Sprague\u2013Dawley rats","volume":"31","author":"Ozcan","year":"2015","journal-title":"Reprod Biomed Online"},{"key":"2019111117231231000_ref124","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1016\/j.fertnstert.2009.02.054","article-title":"Prevention of paclitaxel and cisplatin induced ovarian damage in rats by a gonadotropin-releasing hormone agonist","volume":"93","author":"Ozcelik","year":"2010","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref125","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/90.18.1361","article-title":"erbB-2 and response to doxorubicin in patients with axillary lymph node-positive, hormone receptor-negative breast cancer","volume":"90","author":"Paik","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"2019111117231231000_ref126","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1186\/1471-2407-5-76","article-title":"The proteasome inhibitor MG-132 sensitizes PC-3 prostate cancer cells to ionizing radiation by a DNA-PK-independent mechanism","volume":"5","author":"Pajonk","year":"2005","journal-title":"BMC Cancer"},{"key":"2019111117231231000_ref127","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/jpi.12288","article-title":"Melatonin sensitizes human cervical cancer HeLa cells to cisplatin-induced cytotoxicity and apoptosis: effects on oxidative stress and DNA fragmentation","volume":"60","author":"Pariente","year":"2016","journal-title":"J Pineal Res"},{"key":"2019111117231231000_ref128","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1093\/humrep\/dey045","article-title":"Ceramide-1-phosphate has protective properties against cyclophosphamide-induced ovarian damage in a mice model of premature ovarian failure","volume":"33","author":"Pascuali","year":"2018","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref129","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1038\/nm1197-1228","article-title":"Apoptosis-associated signaling pathways are required for chemotherapy-mediated female germ cell destruction","volume":"3","author":"Perez","year":"1997","journal-title":"Nat Med"},{"key":"2019111117231231000_ref130","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.taap.2011.03.012","article-title":"Detection of DNA damage in oocytes of small ovarian follicles following phosphoramide mustard exposures of cultured rodent ovaries in vitro","volume":"253","author":"Petrillo","year":"2011","journal-title":"Toxicol Appl Pharmacol"},{"key":"2019111117231231000_ref131","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1095\/biolreprod.114.126136","article-title":"Tamoxifen prevents apoptosis and follicle loss from cyclophosphamide in cultured rat ovaries","volume":"92","author":"Piasecka-Srader","year":"2015","journal-title":"Biol Reprod"},{"key":"2019111117231231000_ref132","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/0041-008X(91)90310-B","article-title":"Phosphoramide mustard is responsible for the ovarian toxicity of cyclophosphamide","volume":"107","author":"Plowchalk","year":"1991","journal-title":"Toxicol Appl Pharmacol"},{"key":"2019111117231231000_ref133","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1186\/s12958-018-0426-y","article-title":"Protective effects of mangafodipir against chemotherapy-induced ovarian damage in mice","volume":"16","author":"Qin","year":"2018","journal-title":"Reprod Biol Endocrinol"},{"key":"2019111117231231000_ref134","first-page":"369","article-title":"Ovarian folliculogenesis: detrimental effect of prenatal exposure to cyclophosphamide: a preliminary study","volume":"111","author":"Ray","year":"2010","journal-title":"Bratisl Lek Listy"},{"key":"2019111117231231000_ref135","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1126\/science.1152257","article-title":"Oocyte-specific deletion of Pten causes premature activation of the primordial follicle pool","volume":"319","author":"Reddy","year":"2008","journal-title":"Science"},{"key":"2019111117231231000_ref136","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.2217\/fon-2018-0210","article-title":"Risk-benefit of dexrazoxane for preventing anthracycline-related cardiotoxicity: re-evaluating the European labeling","volume":"14","author":"Reichardt","year":"2018","journal-title":"Future Oncol"},{"key":"2019111117231231000_ref137","doi-asserted-by":"crossref","first-page":"7231","DOI":"10.3390\/ijms14047231","article-title":"Peripheral reproductive organ health and melatonin: ready for prime time","volume":"14","author":"Reiter","year":"2013","journal-title":"Int J Mol Sci"},{"key":"2019111117231231000_ref138","doi-asserted-by":"crossref","first-page":"83","DOI":"10.3109\/09513590.2013.849238","article-title":"Clinical relevance of melatonin in ovarian and placental physiology: a review","volume":"30","author":"Reiter","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"2019111117231231000_ref139","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1534\/genetics.117.203455","article-title":"Pharmacological inhibition of the DNA damage checkpoint prevents radiation-induced oocyte death","volume":"206","author":"Rinaldi","year":"2017","journal-title":"Genetics"},{"key":"2019111117231231000_ref140","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1021\/bk-1983-0209.ch001","volume-title":"Platinum, Gold, and Other Metal Chemotherapeutic Agents: Chemistry and Biochemistry","author":"Roberts","year":"1983"},{"key":"2019111117231231000_ref141","doi-asserted-by":"crossref","first-page":"3245","DOI":"10.4161\/cc.26358","article-title":"Ovarian follicle burnout: a universal phenomenon?","volume":"12","author":"Roness","year":"2013","journal-title":"Cell Cycle"},{"key":"2019111117231231000_ref142","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1093\/humupd\/dmu019","article-title":"Prevention of chemotherapy-induced ovarian damage: possible roles for hormonal and non-hormonal attenuating agents","volume":"20","author":"Roness","year":"2014","journal-title":"Hum Reprod Update"},{"key":"2019111117231231000_ref143","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.fertnstert.2015.11.043","article-title":"Prevention of chemotherapy-induced ovarian damage","volume":"105","author":"Roness","year":"2016","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref144","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1038\/cdd.2016.97","article-title":"LH prevents cisplatin-induced apoptosis in oocytes and preserves female fertility in mouse","volume":"24","author":"Rossi","year":"2017","journal-title":"Cell Death Differ"},{"key":"2019111117231231000_ref145","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0042293","article-title":"Acute doxorubicin insult in the mouse ovary is cell- and follicle-type dependent","volume":"7","author":"Roti Roti","year":"2012","journal-title":"PLoS One"},{"key":"2019111117231231000_ref146","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0108174","article-title":"Bortezomib prevents acute doxorubicin ovarian insult and follicle demise, improving the fertility window and pup birth weight in mice","volume":"9","author":"Roti Roti","year":"2014","journal-title":"PLoS One"},{"key":"2019111117231231000_ref147","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1095\/biolreprod.111.097030","article-title":"Dexrazoxane ameliorates doxorubicin-induced injury in mouse ovarian cells","volume":"86","author":"Roti Roti","year":"2012","journal-title":"Biol Reprod"},{"key":"2019111117231231000_ref148","doi-asserted-by":"crossref","first-page":"41","DOI":"10.3390\/cancers9050041","article-title":"Targeting the ATR-CHK1 Axis in cancer therapy","volume":"9","author":"Rundle","year":"2017","journal-title":"Cancers (Basel)"},{"key":"2019111117231231000_ref149","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1177\/0960327114564793","article-title":"Tocotrienol preserves ovarian function in cyclophosphamide therapy","volume":"34","author":"Saleh","year":"2015","journal-title":"Hum Exp Toxicol"},{"key":"2019111117231231000_ref150","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1016\/j.fertnstert.2011.01.128","article-title":"Retrovirus-mediated multidrug resistance gene (MDR1) overexpression inhibits chemotherapy-induced toxicity of granulosa cells","volume":"95","author":"Salih","year":"2011","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref151","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1095\/biolreprod.114.119495","article-title":"Dexrazoxane abrogates acute doxorubicin toxicity in marmoset ovary","volume":"92","author":"Salih","year":"2015","journal-title":"Biol Reprod"},{"key":"2019111117231231000_ref152","doi-asserted-by":"crossref","first-page":"3834","DOI":"10.3390\/ijms14023834","article-title":"Crosstalk between oxidative stress and SIRT1: impact on the aging process","volume":"14","author":"Salminen","year":"2013","journal-title":"Int J Mol Sci"},{"key":"2019111117231231000_ref153","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.mce.2004.12.010","article-title":"Anti-Mullerian hormone initiates growth of human primordial follicles in vitro","volume":"234","author":"Schmidt","year":"2005","journal-title":"Mol Cell Endocrinol"},{"key":"2019111117231231000_ref154","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.str.2007.01.015","article-title":"C-Src binds to the cancer drug imatinib with an inactive Abl\/c-kit conformation and a distributed thermodynamic penalty","volume":"15","author":"Seeliger","year":"2007","journal-title":"Structure"},{"key":"2019111117231231000_ref155","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1038\/sj.onc.1206933","article-title":"Cisplatin: mode of cytotoxic action and molecular basis of resistance","volume":"22","author":"Siddik","year":"2003","journal-title":"Oncogene"},{"key":"2019111117231231000_ref156","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1200\/JCO.2011.37.2938","article-title":"Congenital anomalies in the children of cancer survivors: a report from the childhood cancer survivor study","volume":"30","author":"Signorello","year":"2012","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref157","doi-asserted-by":"crossref","first-page":"2045","DOI":"10.1016\/j.fertnstert.2013.01.135","article-title":"Granulocyte colony-stimulating factor with or without stem cell factor extends time to premature ovarian insufficiency in female mice treated with alkylating chemotherapy","volume":"99","author":"Skaznik-Wikiel","year":"2013","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref158","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1023\/A:1016119328968","article-title":"Poly (ADP-ribose) polymerase-1 cleavage during apoptosis: an update","volume":"7","author":"Soldani","year":"2002","journal-title":"Apoptosis"},{"key":"2019111117231231000_ref159","doi-asserted-by":"crossref","first-page":"782","DOI":"10.18632\/aging.100363","article-title":"Mechanisms of chemotherapy-induced human ovarian aging: double strand DNA breaks and microvascular compromise","volume":"3","author":"Soleimani","year":"2011","journal-title":"Aging (Albany NY)"},{"key":"2019111117231231000_ref160","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1096\/fj.201801089R","article-title":"AMH prevents primordial ovarian follicle loss and fertility alteration in cyclophosphamide-treated mice","volume":"33","author":"Sonigo","year":"2018","journal-title":"FASEB J"},{"key":"2019111117231231000_ref161","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1038\/nature05337","article-title":"p63 protects the female germ line during meiotic arrest","volume":"444","author":"Suh","year":"2006","journal-title":"Nature"},{"key":"2019111117231231000_ref162","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1080\/15384101.2014.995496","article-title":"New strategy for in vitro activation of primordial follicles with mTOR and PI3K stimulators","volume":"14","author":"Sun","year":"2015","journal-title":"Cell Cycle"},{"key":"2019111117231231000_ref163","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1007\/s10549-011-1593-0","article-title":"Interaction between goserelin and tamoxifen in a prospective randomised clinical trial of adjuvant endocrine therapy in premenopausal breast cancer","volume":"128","author":"Sverrisdottir","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"2019111117231231000_ref164","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1007\/s10549-009-0313-5","article-title":"Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial","volume":"117","author":"Sverrisdottir","year":"2009","journal-title":"Breast Cancer Res Treat"},{"key":"2019111117231231000_ref165","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1538\/expanim.18-0042","article-title":"Protective effect of a mechanistic target of rapamycin inhibitor on an in vivo model ofcisplatin-induced ovarian gonadotoxicity","volume":"67","author":"Tanaka","year":"2018","journal-title":"Exp Anim"},{"key":"2019111117231231000_ref166","doi-asserted-by":"crossref","first-page":"272","DOI":"10.3109\/09513590.2014.984679","article-title":"Protective effects of sildenafil citrate administration on cisplatin-induced ovarian damage in rats","volume":"31","author":"Taskin","year":"2015","journal-title":"Gynecol Endocrinol"},{"key":"2019111117231231000_ref167","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1097\/FPC.0b013e32833ffb56","article-title":"Doxorubicin pathways: pharmacodynamics and adverse effects","volume":"21","author":"Thorn","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"2019111117231231000_ref168","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s10815-010-9463-y","article-title":"Tamoxifen decreases ovarian follicular loss from experimental toxicant DMBA and chemotherapy agents cyclophosphamide and doxorubicin in the rat","volume":"27","author":"Ting","year":"2010","journal-title":"J Assist Reprod Genet"},{"key":"2019111117231231000_ref169","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.yjmcc.2006.06.009","article-title":"New insights into doxorubicin-induced cardiotoxicity: the critical role of cellular energetics","volume":"41","author":"Tokarska-Schlattner","year":"2006","journal-title":"J Mol Cell Cardiol"},{"key":"2019111117231231000_ref170","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.steroids.2014.10.010","article-title":"Protective effect of dienogest on chemotherapy-induced reduced fertility in female rats","volume":"93","author":"Tsuyoshi","year":"2015","journal-title":"Steroids"},{"key":"2019111117231231000_ref171","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41594-018-0035-7","article-title":"Oocyte DNA damage quality control requires consecutive interplay of CHK2 and CK1 to activate p63","volume":"25","author":"Tuppi","year":"2018","journal-title":"Nat Struct Mol Biol"},{"key":"2019111117231231000_ref172","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1200\/JCO.2017.76.3441","article-title":"Reproductive function and outcomes in female survivors of childhood, adolescent, and young adult cancer: a review","volume":"36","author":"Dorp","year":"2018","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref173","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S2352-4642(17)30091-3","article-title":"Effects of cancer treatment during pregnancy on fetal and child development","volume":"1","author":"Vandenbroucke","year":"2017","journal-title":"Lancet Child Adolesc Health"},{"key":"2019111117231231000_ref174","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1111\/j.1600-079X.2011.00931.x","article-title":"Extrapineal melatonin: analysis of its subcellular distribution and daily fluctuations","volume":"52","author":"Venegas","year":"2012","journal-title":"J Pineal Res"},{"key":"2019111117231231000_ref175","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.fertnstert.2014.06.003","article-title":"Gonadotropin-releasing hormone agonists for the preservation of ovarian function among women with breast cancer who did not use tamoxifen after chemotherapy: a systematic review and meta-analysis","volume":"102","author":"Vitek","year":"2014","journal-title":"Fertil Steril"},{"key":"2019111117231231000_ref176","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/nrd1691","article-title":"Cellular processing of platinum anticancer drugs","volume":"4","author":"Wang","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"2019111117231231000_ref177","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1093\/toxsci\/kfy038","article-title":"Multidrug resistance protein 1 deficiency promotes doxorubicin-induced ovarian toxicity in female mice","volume":"163","author":"Wang","year":"2018","journal-title":"Toxicol Sci"},{"key":"2019111117231231000_ref178","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1093\/humupd\/dmu061","article-title":"Environmental epigenetic inheritance through gametes and implications for human reproduction","volume":"21","author":"Wei","year":"2015","journal-title":"Hum Reprod Update"},{"key":"2019111117231231000_ref179","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ygyno.2011.01.003","article-title":"Survival and reproductive outcomes in women treated for malignant ovarian germ cell tumors","volume":"121","author":"Weinberg","year":"2011","journal-title":"Gynecol Oncol"},{"key":"2019111117231231000_ref180","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1095\/biolreprod.114.123570","article-title":"Ghrelin partially protects against cisplatin-induced male murine gonadal toxicity in a GHSR-1a-dependent manner","volume":"92","author":"Whirledge","year":"2015","journal-title":"Biol Reprod"},{"key":"2019111117231231000_ref181","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1399-0004.2008.01109.x","article-title":"Radiotherapy for childhood cancer and risk for congenital malformations in offspring: a population-based cohort study","volume":"75","author":"Winther","year":"2009","journal-title":"Clin Genet"},{"key":"2019111117231231000_ref182","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1200\/JCO.2011.35.0504","article-title":"Genetic disease in the children of Danish survivors of childhood and adolescent cancer","volume":"30","author":"Winther","year":"2012","journal-title":"J Clin Oncol"},{"key":"2019111117231231000_ref183","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1016\/j.cell.2006.01.016","article-title":"TOR signaling in growth and metabolism","volume":"124","author":"Wullschleger","year":"2006","journal-title":"Cell"},{"key":"2019111117231231000_ref184","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.phymed.2006.11.028","article-title":"Pharmacokinetic properties of crocin (crocetin digentiobiose ester) following oral administration in rats","volume":"14","author":"Xi","year":"2007","journal-title":"Phytomedicine"},{"key":"2019111117231231000_ref185","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/toxsci\/kfx047","article-title":"Doxorubicin has dose-dependent toxicity on mouse ovarian follicle development, hormone secretion, and oocyte maturation","volume":"157","author":"Xiao","year":"2017","journal-title":"Toxicol Sci"},{"key":"2019111117231231000_ref186","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1016\/j.phrs.2012.10.010","article-title":"Negative regulation of inflammation by SIRT1","volume":"67","author":"Xie","year":"2013","journal-title":"Pharmacol Res"},{"key":"2019111117231231000_ref187","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.bbrc.2006.06.195","article-title":"Mullerian inhibiting substance as a novel biomarker of cisplatin-induced ovarian damage","volume":"348","author":"Yeh","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"2019111117231231000_ref188","doi-asserted-by":"crossref","first-page":"463.e461","DOI":"10.1016\/j.ajog.2007.12.027","article-title":"Protection against cisplatin-induced ovarian damage by the antioxidant sodium 2-mercaptoethanesulfonate (mesna) in female rats","volume":"198","author":"Yeh","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"2019111117231231000_ref189","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1479-828X.2004.00143.x","article-title":"Effect of chemotherapy on primordial follicular reserve of rat: an animal model of premature ovarian failure and infertility","volume":"44","author":"Yucebilgin","year":"2004","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"2019111117231231000_ref190","first-page":"2926","article-title":"The magnitude of gonadotoxicity of chemotherapy drugs on ovarian follicles and granulosa cells varies depending upon the category of the drugs and the type of granulosa cells","volume":"30","author":"Yuksel","year":"2015","journal-title":"Hum Reprod"},{"key":"2019111117231231000_ref191","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.1634\/theoncologist.2011-0137","article-title":"Will imatinib compromise reproductive capacity?","volume":"16","author":"Zamah","year":"2011","journal-title":"Oncologist"},{"key":"2019111117231231000_ref192","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.yrtph.2017.02.012","article-title":"Effect of doxorubicin-induced ovarian toxicity on mouse ovarian granulosa cells","volume":"86","author":"Zhang","year":"2017","journal-title":"Regul Toxicol Pharmacol"},{"key":"2019111117231231000_ref193","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13048-017-0350-3","article-title":"Rapamycin prevents cyclophosphamide-induced over-activation of primordial follicle pool through PI3K\/Akt\/mTOR signaling pathway in vivo","volume":"10","author":"Zhou","year":"2017","journal-title":"J Ovarian Res"}],"container-title":["Human Reproduction Update"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/25\/6\/673\/30648064\/dmz027.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/academic.oup.com\/humupd\/article-pdf\/25\/6\/673\/30648064\/dmz027.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,11]],"date-time":"2019-11-11T17:31:58Z","timestamp":1573493518000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/humupd\/article\/25\/6\/673\/5585503"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,10,10]]},"references-count":192,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2019,10,10]]},"published-print":{"date-parts":[[2019,11,5]]}},"URL":"https:\/\/doi.org\/10.1093\/humupd\/dmz027","relation":{},"ISSN":["1355-4786","1460-2369"],"issn-type":[{"value":"1355-4786","type":"print"},{"value":"1460-2369","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2019,11]]},"published":{"date-parts":[[2019,10,10]]}}}